Skip to content
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS

“The coronavirus is a moving target” – article on the Axios.com news platform

  • Posted on May 9, 2020

Mark Poznansky was interviewed by Alison Snyder of Axios and this article includes a number of his thoughts on how the virus is evolving and how vaccines must be able to react to these changes.

Click to read full article on the Axios.com news platform
FacebookTwitter

Recommended Posts

Restoring p53 function with mRNA nanoparticles and immune checkpoint blockade to enhance immunotherapy
181 Nobel Laureates condemn Vladimir Putin’s unprovoked and brutal invasion of Ukraine.
Exciting research reveals new potential in investigating “hybrid immunity” against Covid-19 and evolving variant
Three pillars of pandemic preparedness to end this one while preparing for the next
Vaccine & Immunotherapy Center
Accelerating discovery and development of new products addressing unmet clinical need.
Facebook-f Twitter Youtube

INFORMATION

  • CAREERS
  • Directions
  • Advisors
  • Management
  • Collaborators
  • Support VIC

CONTACT

149 13th Street, 5th Floor
Charlestown Navy Yard,
MA 02129-2020

Phone  :  1-617-643-2098
Email    :  VIC@partners.org

© 2023 VACCINE & IMMUNOTHERAPY CENTER. ALL RIGHTS RESERVED |  Site by OLP